| Zacks Company Profile for Panacea Life Sciences Holdings, Inc. (PLSH : OTC) |
|
|
| |
| • Company Description |
| Panacea Life Sciences is involved in production of legal, trace THC, hemp-derived cannabinoid products for consumers and pets. The company produces soft gels, gummies, tinctures, sublingual tablets, cosmetics and other topicals for purchase online and in stores as well as in smart kiosk vending machines. Panacea Life Sciences, formerly known as Exactus Inc., is based in DELRAY BEACH, FL.
Number of Employees: |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $0.06 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 8,567 shares |
| Shares Outstanding: 21.22 (millions) |
| Market Capitalization: $1.27 (millions) |
| Beta: 2.62 |
| 52 Week High: $0.12 |
| 52 Week Low: $0.03 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
15.39% |
12.36% |
| 12 Week |
30.43% |
25.03% |
| Year To Date |
140.00% |
109.78% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
5910 S University Blvd C18-193
-
Greenwood Village,CO 80121
USA |
ph: 800-985-0515
fax: - |
None |
http://www.panacealife.com |
|
|
| |
| • General Corporate Information |
Officers
Leslie Buttorff - Chief Executive Officer; Chairman and Chief Financ
Nick Cavarra - President
Nathan Berman - Controller
Lawrence J. Wert - Director
James Baumgartner - Chief Science Officer and Quality Control
|
|
Peer Information
Panacea Life Sciences Holdings, Inc. (BJCT)
Panacea Life Sciences Holdings, Inc. (CADMQ)
Panacea Life Sciences Holdings, Inc. (APNO)
Panacea Life Sciences Holdings, Inc. (UPDC)
Panacea Life Sciences Holdings, Inc. (IMTIQ)
Panacea Life Sciences Holdings, Inc. (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 69810P109
SIC: 2833
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 11/11/25
|
|
Share - Related Items
Shares Outstanding: 21.22
Most Recent Split Date: 10.00 (0.04:1)
Beta: 2.62
Market Capitalization: $1.27 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 11/11/25 |
|
|
|
| |
